Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    Open Studies | "Rhinitis, Allergic, Seasonal"
Show Display Options
Rank Status Study
1 Recruiting Phase II Study of Grass Pollen Allergy Vaccine BM32
Condition: Grass Pollen Allergy
Interventions: Biological: BM32;   Biological: Placebo
2 Unknown  Observational Study With PASCALLERG ® in Patients With Hay Fever
Condition: Hay Fever
Intervention:
3 Not yet recruiting Efficacy and Safety of S0597 in Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: S0597 low dose;   Drug: S0597 mid dose;   Drug: S0597 high dose;   Drug: Reference
4 Recruiting Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Ciclesonide;   Drug: Ciclesonide Placebo
5 Recruiting Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: montelukast;   Drug: cetirizine;   Drug: montelukast and cetirizine;   Drug: placebo
6 Recruiting Efficacy Park Study Assessing Rhinix™ Nasal Filters for Hay Fever
Condition: Seasonal Allergic Rhinitis
Interventions: Device: Placebo Filter;   Device: Rhinix Nasal Filter
7 Recruiting Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray;   Drug: Placebo nasal spray
8 Recruiting Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (MK-3641-006)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641 12 Amb a 1-U (short ragweed extract);   Biological: MK-7243 2800 BAU (Timothy grass extract);   Drug: Rescue Medication
9 Unknown  Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
Conditions: Rhinitis, Allergic, Perennial;   Rhinitis, Allergic, Seasonal;   Skin Prick Test
Intervention:
10 Not yet recruiting Effect of the Nasal Provocation on the Breathing Style
Conditions: Birch Pollen Allergy;   Healthy Control Subjects
Intervention: Biological: 1. session birch pollen nasal exposure 2. session xylometazoline nasal exposure
11 Unknown  Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy
Conditions: Birch Pollen Related Apple Allergy;   Birch Pollen Allergy
Interventions: Drug: rMal d 1;   Drug: rBet v 1;   Other: placebo drops
12 Recruiting Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine hydrochloride and Fluticasone propionate;   Drug: Dymista™;   Other: Placebo
13 Recruiting Contac Bien Z Adverse Effect Survey
Conditions: Allergic Rhinitis;   Seasonal Allergic Rhinitis
Intervention: Other: Cetrizine hydrochloride
14 Recruiting Allergic Rhinitis Changes the Sinus Microbiome
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: QNASL;   Drug: Placebo nasal spray
15 Recruiting Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Phleum pratense grass pollen allergen extract;   Drug: placebo
16 Recruiting Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma
Conditions: Seasonal Allergic Rhinitis;   Asthma
Interventions: Biological: Grass-SPIRE;   Biological: Placebo
17 Recruiting To Determine the Minimum Amount of Artemisia Vulgaris Allergen Extract Producing a Positive Skin Reaction.
Condition: Allergy to Pollen
Intervention: Biological: Artemisia vulgaris
18 Not yet recruiting Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Other: Grass pollen sublingual immunotherapy tablet;   Drug: Control
19 Unknown  A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
20 Unknown  Efficacy and Safety of Sublingual Immunotherapy (SLIT)
Condition: Allergic Rhinitis
Interventions: Biological: sublingual immunotherapy with allergen extract;   Biological: sublingual immunotherapy with placebo

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years